Advancing treatments for rare diseases together
  • Our focus

    Watch our Founder talk about EspeRare
  • Addressing genetic rare diseases

    We focus on developing treatments for debilitating rare diseases with high unmet medical needs
  • Patient-centric approach

    EspeRare fully engages the patient community at each step of the drug development process

Our mission and vision

We aim to give children and their families, affected by the orphan diseases, a fair access to life-changing therapies and a new hope for the future.

Our model

Hand-in-hand with patients, EspeRare rescues and repositions therapies in rare diseases, thus accelerating the development of accessible treatments for these underserved patients.

R&D programmes

EspeRare is building a diversified portfolio of programmes with strong therapeutic potential. Today, our programmes include genetic diseases affecting muscle, heart and skin.

Recent news

29Feb
Today is a very special day, Rare Disease Day! A day that gives us the opportunity to shine a spotlight on patients and families living with rare...
22Feb
On February 20, 2024, the EspeRare Foundation and Pierre Fabre Laboratories received a prestigious EURORDIS Company Award for Patient Engagement. It...

Testimonials

  • It is time to renovate and accelerate the discovery and development of drugs for rare diseases. Esperare is an essential player in the innovative, collaborative system that will be created to make a difference in this world.
    Sharon Terry
    President of EspeRare and CEO of Genetic Alliance
  • As a nonprofit organisation, our priorities are not determined by the size of a market, they are solely defined by the medical needs and great science. Above all, we strive to apply our patient-centric model and pharma know-how to advance new treatments for underserved patients.
    Caroline Kant
    EspeRare's Founder and Executive Director
  • For me it is a privilege to represent Merck Serono on the Board of EspeRare, I firmly believe that this exciting new Foundation can make a real difference to the lives of patients with Duchenne Muscular Dystrophy and other rare diseases.
    Ewen Sedman
    Board member
  • Fostering access to health for patients that are the most in need is what this foundation is about, and is what I am about.
    Beatrice Greco
    EspeRare's Founder and Member of the Board
  • Duchenne is a heartbreaking disease. Children like Laurent, my cousin, affected with this disease are bright and engaged but as they grow up, they inexorably get weaker and experience the loss of the few abilities they had acquired. I have in my genes the eagerness to find treatments for this disease and I am committed to give them the strength to fight their disease.
    Florence Porte
    EspeRare's Founder and R&D Director